| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical (N.A., S.P.) and Nuclear Medicine Services (W.E.B., N.F.), Department of Veterans Affairs, Edward Hines Jr. Hospital, Hines, Illinois 60141; and Departments of Medicine (N.A., S.P.) and Nuclear Medicine (W.E.B., N.F.), Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153
Address all correspondence and requests for reprints to: Nasrin Azad, M.D. (111A), Edward Hines Jr. Veterans Affairs Hospital, Medical Service/ Endocrinology Section, Building 200, Suite 1422, Hines, Illinois 60141. E-mail: nasrin.azad{at}med.va.gov.
The positive effect of testosterone replacement therapy on psychosocial well-being in hypogonadal men has been demonstrated by various psychometric tests. However, there is no report available that objectively demonstrates the effect of testosterone on the function of the central nervous system in men. In this report we studied cerebral perfusion in seven hypogonadal men on testosterone replacement therapy. The blood perfusion to the central nervous system was assessed using single-photon emission-computed tomography. 99 mTc-hexamethyl-propylene-amine oxime crosses the blood brain barrier and localizes in brain tissue, depending on the intensity of the local blood flow. Psychosocial well-being was assessed with an Androgen Deficiency in Aging Men questionnaire. The study demonstrated that testosterone replacement enhanced cerebral perfusion in midbrain and superior frontal gyrus (Brodman area 8) at 35 wk of treatment. At 1214 wk the study continued to show increased perfusion in midbrain in addition to the appearance of a new activated region in the midcingulate gyrus (Brodman area 24). The results of this study provide objective evidence that testosterone and /or its metabolites increased cerebral perfusion in addition to the improvement in cognitive function.
This work was supported by a grant from Illinois AMVETS.
Abbreviations: ADAM, Androgen Deficiency in Aging Men questionnaire; CNS, central nervous system; HMPAO, 99mTc-hexamethyl-propylene-amine-oxime; H-P-G, hypothalamic-pituitary-gonadal; MNI, Montreal Neurological Institute; SPECT, single-photon emission-computed tomography; SPM, statistical parametric mapping.
This article has been cited by other articles:
![]() |
M Ebinger, C Sievers, D Ivan, H. Schneider, and G. Stalla Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J Psychopharmacol, September 1, 2009; 23(7): 841 - 853. [Abstract] [PDF] |
||||
![]() |
P. M. Maki, M. Ernst, E. D. London, K. L. Mordecai, P. Perschler, S. C. Durso, J. Brandt, A. Dobs, and S. M. Resnick Intramuscular Testosterone Treatment in Elderly Men: Evidence of Memory Decline and Altered Brain Function J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4107 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rothman, D. B. Arciniegas, C. M. Filley, and M. E. Wierman The Neuroendocrine Effects of Traumatic Brain Injury J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 363 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tontisirin, S. L. Muangman, P. Suz, C. Pihoker, D. Fisk, A. Moore, A. M. Lam, and M. S. Vavilala Early Childhood Gender Differences in Anterior and Posterior Cerebral Blood Flow Velocity and Autoregulation Pediatrics, March 1, 2007; 119(3): e610 - e615. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Beauchet Testosterone and cognitive function: current clinical evidence of a relationship Eur. J. Endocrinol., December 1, 2006; 155(6): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Gray, A. B. Singh, L. J. Woodhouse, T. W. Storer, R. Casaburi, J. Dzekov, C. Dzekov, I. Sinha-Hikim, and S. Bhasin Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3838 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
R E Ready, J Friedman, J Grace, and H Fernandez Testosterone deficiency and apathy in Parkinson's disease: a pilot study J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1323 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Littleton-Kearney and P. D. Hurn Testosterone as a Modulator of Vascular Behavior Biol Res Nurs, April 1, 2004; 5(4): 276 - 285. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |